SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001372514-24-000111
Filing Date
2024-08-20
Accepted
2024-08-20 13:00:12
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724173206.html 4  
1 FORM 4 wk-form4_1724173206.xml 4 3618
  Complete submission text file 0001372514-24-000111.txt   5228
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DARE BIOSCIENCE, INC. 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Walters-Hoffert Lisa (Reporting) CIK: 0001711576 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 241223999